Tapewire

Nasdaq · USD

TBPH

Theravance Biopharma, Inc.

Export transactions ↓
Tapewire entity
5037
SEC CIK
0001583107
Parsed reports
533

Last 12 months

Inside the activity.

0 purchase rows · 25 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202508
Dec 202503
Jan 202600
Feb 202600
Mar 202603
Apr 202600
May 202600
Jun 202605
Jul 202603
Aug 202600
Sep 202603
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 08, 2024 Filed May 10, 2024 18:04 UTC GrantShare Option (Right to Buy) · Derivative 23,576 $0.00 Strike: $9.49 $0.00
Disclosure

SEC source: 0001415889-24-012911 · form4-05102024_100529.xml · derivative · entry 2

Grant Jeremy T · CIK 0002004368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,576

Underlying: Ordinary Shares · 23,576 shares

Expires 2034-05-07

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 08, 2024 Filed May 10, 2024 18:04 UTC GrantOrdinary Shares 10,537 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-012911 · form4-05102024_100529.xml · nonDerivative · entry 1

Grant Jeremy T · CIK 0002004368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,305

Read SEC document
May 08, 2024 Filed May 10, 2024 22:12 UTC GrantShare Option (Right to Buy) · Derivative 23,576 $0.00 Strike: $9.49 $0.00
Disclosure

SEC source: 0001415889-24-012919 · form4-05102024_100512.xml · derivative · entry 2

PAKIANATHAN DEEPIKA · CIK 0001270734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,576

Underlying: Ordinary Shares · 23,576 shares

Expires 2034-05-07

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 08, 2024 Filed May 10, 2024 22:12 UTC GrantOrdinary Shares 10,537 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-012919 · form4-05102024_100512.xml · nonDerivative · entry 1

PAKIANATHAN DEEPIKA · CIK 0001270734 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,416

Read SEC document
May 08, 2024 Filed May 10, 2024 22:09 UTC GrantShare Option (Right to Buy) · Derivative 23,576 $0.00 Strike: $9.49 $0.00
Disclosure

SEC source: 0001415889-24-012915 · form4-05102024_100546.xml · derivative · entry 2

MITCHELL DEAN J · CIK 0001199297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,576

Underlying: Ordinary Shares · 23,576 shares

Expires 2034-05-07

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 08, 2024 Filed May 10, 2024 22:09 UTC GrantOrdinary Shares 10,537 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-012915 · form4-05102024_100546.xml · nonDerivative · entry 1

MITCHELL DEAN J · CIK 0001199297 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,555

Read SEC document
May 08, 2024 Filed May 10, 2024 22:02 UTC
BROSHY ERANDirector
GrantShare Option (Right to Buy) · Derivative 23,576 $0.00 Strike: $9.49 $0.00
Disclosure

SEC source: 0001415889-24-012908 · form4-05102024_100548.xml · derivative · entry 2

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,576

Underlying: Ordinary Shares · 23,576 shares

Expires 2034-05-07

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 08, 2024 Filed May 10, 2024 22:02 UTC
BROSHY ERANDirector
GrantOrdinary Shares 10,537 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-012908 · form4-05102024_100548.xml · nonDerivative · entry 1

BROSHY ERAN · CIK 0001256230 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,555

Read SEC document
May 08, 2024 Filed May 10, 2024 22:10 UTC GrantShare Option (Right to Buy) · Derivative 23,576 $0.00 Strike: $9.49 $0.00
Disclosure

SEC source: 0001415889-24-012917 · form4-05102024_100546.xml · derivative · entry 2

O'Connor Donal · CIK 0001625377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,576

Underlying: Ordinary Shares · 23,576 shares

Expires 2034-05-07

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 08, 2024 Filed May 10, 2024 22:10 UTC GrantOrdinary Shares 10,537 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-012917 · form4-05102024_100546.xml · nonDerivative · entry 1

O'Connor Donal · CIK 0001625377 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,555

Read SEC document
May 08, 2024 Filed May 10, 2024 22:06 UTC GrantShare Option (Right to Buy) · Derivative 23,576 $0.00 Strike: $9.49 $0.00
Disclosure

SEC source: 0001415889-24-012913 · form4-05102024_100550.xml · derivative · entry 2

GRAY SUSANNAH · CIK 0001833453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,576

Underlying: Ordinary Shares · 23,576 shares

Expires 2034-05-07

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 08, 2024 Filed May 10, 2024 22:06 UTC GrantOrdinary Shares 10,537 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-012913 · form4-05102024_100550.xml · nonDerivative · entry 1

GRAY SUSANNAH · CIK 0001833453 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,488

Read SEC document
May 08, 2024 Filed May 10, 2024 22:01 UTC GrantShare Option (Right to Buy) · Derivative 23,576 $0.00 Strike: $9.49 $0.00
Disclosure

SEC source: 0001415889-24-012906 · form4-05102024_100555.xml · derivative · entry 2

Smaldone Alsup Laurie · CIK 0001589602 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,576

Underlying: Ordinary Shares · 23,576 shares

Expires 2034-05-07

F1 · derivative.exercise_date: This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.

Read SEC document
May 08, 2024 Filed May 10, 2024 22:01 UTC GrantOrdinary Shares 10,537 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-012906 · form4-05102024_100555.xml · nonDerivative · entry 1

Smaldone Alsup Laurie · CIK 0001589602 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,331

Read SEC document
May 01, 2024 Filed May 3, 2024 20:19 UTC
Samaha Eli10% owner
PurchaseCOM 499,324 $8.75 $4,369,085.00
Disclosure

SEC source: 0001877589-24-000001 · primary_doc.xml · nonDerivative · entry 2

Samaha Eli · CIK 0001877589 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 8,511,350

F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.

Read SEC document
May 01, 2024 Filed May 3, 2024 20:19 UTC
Samaha Eli10% owner
PurchaseCOM 999,800 $8.75 $8,748,250.00
Disclosure

SEC source: 0001877589-24-000001 · primary_doc.xml · nonDerivative · entry 1

Samaha Eli · CIK 0001877589 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 8,012,026

F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 22:13 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
GrantOrdinary Shares 37,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010324 · form4-04042024_100429.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 171,034

Read SEC document
April 02, 2024 Filed Apr 4, 2024 22:11 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
GrantOrdinary Shares 100,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010322 · form4-04042024_100443.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360,684

F1 · shares: On April 2, 2024, the reporting person was granted 100,000 RSUs. 37,500 RSUs are subject to service-based vesting conditions and the remaining 62,500 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 22:09 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
GrantOrdinary Shares 37,500 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010320 · form4-04042024_100416.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,233

Read SEC document
April 02, 2024 Filed Apr 4, 2024 22:17 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GrantOrdinary Shares 300,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010328 · form4-04042024_100427.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,850,573

F1 · shares: On April 2, 2024, the reporting person was granted 300,000 RSUs. 150,000 RSUs are subject to service-based vesting conditions and the remaining 150,000 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 22:15 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
GrantOrdinary Shares 100,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-010326 · form4-04042024_100421.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 338,636

F1 · shares: On April 2, 2024, the reporting person was granted 100,000 RSUs. 37,500 RSUs are subject to service-based vesting conditions and the remaining 62,500 RSUs vest based on the achievement of share price appreciation targets as well as continued employment.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:06 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GiftOrdinary Shares 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008630 · form4-03192024_100308.xml · nonDerivative · entry 4

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Indirect · As Custodian

Disclosed balance after: 3,900

F3 · kind: Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.

F4 · ownership.nature: The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:06 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GiftOrdinary Shares 3,900 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008630 · form4-03192024_100308.xml · nonDerivative · entry 3

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,550,573

F3 · kind: Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:06 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GiftOrdinary Shares 7,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-008630 · form4-03192024_100308.xml · nonDerivative · entry 2

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,554,473

F2 · kind: Bona Fide Gift. No compensation was given to the donor for the gifting of shares.

Read SEC document
March 15, 2024 Filed Mar 19, 2024 22:06 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
GrantOrdinary Shares 2,704 $8.64 $23,362.56
Disclosure

SEC source: 0001415889-24-008630 · form4-03192024_100308.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,561,473

F1 · kind: Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on March 15, 2024. Transaction was with the Issuer and did not involve an open market transaction.

Read SEC document
February 22, 2024 Filed Feb 23, 2024 01:04 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 1,254 $8.71 $10,922.34
Disclosure

SEC source: 0001415889-24-004958 · form4-02232024_010211.xml · nonDerivative · entry 2

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 311,733

F2 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023.

Read SEC document
February 20, 2024 Filed Feb 23, 2024 01:10 UTC
Miller AineSVP, DEV & HEAD OF IRE OFFICE
Tax withholdingOrdinary Shares 11,782 $8.92 $105,095.44
Disclosure

SEC source: 0001415889-24-004964 · form4-02232024_010200.xml · nonDerivative · entry 1

Miller Aine · CIK 0002012524 · SVP, DEV & HEAD OF IRE OFFICE

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,534

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2024 Filed Feb 23, 2024 01:08 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 17,595 $8.92 $156,947.40
Disclosure

SEC source: 0001415889-24-004962 · form4-02232024_010253.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,684

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2024 Filed Feb 23, 2024 01:04 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 18,219 $8.92 $162,513.48
Disclosure

SEC source: 0001415889-24-004958 · form4-02232024_010211.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 312,987

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2024 Filed Feb 23, 2024 01:14 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 37,196 $8.92 $331,788.32
Disclosure

SEC source: 0001415889-24-004968 · form4-02232024_010235.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,558,769

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2024 Filed Feb 23, 2024 01:11 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 17,036 $8.92 $151,961.12
Disclosure

SEC source: 0001415889-24-004966 · form4-02232024_010249.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 238,636

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
February 20, 2024 Filed Feb 23, 2024 01:06 UTC
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
Tax withholdingOrdinary Shares 19,294 $8.92 $172,102.48
Disclosure

SEC source: 0001415889-24-004960 · form4-02232024_010210.xml · nonDerivative · entry 1

GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 314,915

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 18:09 UTC GrantShare Option (Right to Buy) · Derivative 6,578 $0.00 Strike: $11.33 $0.00
Disclosure

SEC source: 0001415889-23-016943 · form4-12262023_111258.xml · derivative · entry 4

Grant Jeremy T · CIK 0002004368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,578

Underlying: Ordinary Shares · 6,578 shares

Expires 2033-12-21

F2 · derivative.exercise_date: This option shall vest monthly over four months of service from the date of grant and will vest in full upon earlier of the four-month anniversary of Jeremy Grant's appointment to the Board or the date of Company's 2024 annual meeting of Shareholders.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 18:09 UTC GrantShare Option (Right to Buy) · Derivative 19,734 $0.00 Strike: $11.33 $0.00
Disclosure

SEC source: 0001415889-23-016943 · form4-12262023_111258.xml · derivative · entry 3

Grant Jeremy T · CIK 0002004368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,734

Underlying: Ordinary Shares · 19,734 shares

Expires 2033-12-21

F1 · derivative.exercise_date: The option vests monthly over 24 months of service from the date of grant.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 18:09 UTC GrantOrdinary Shares 2,942 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-016943 · form4-12262023_111258.xml · nonDerivative · entry 2

Grant Jeremy T · CIK 0002004368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,768

Read SEC document
December 21, 2023 Filed Dec 26, 2023 18:09 UTC GrantOrdinary Shares 8,826 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-016943 · form4-12262023_111258.xml · nonDerivative · entry 1

Grant Jeremy T · CIK 0002004368 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,826

Read SEC document
November 21, 2023 Filed Nov 22, 2023 23:07 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 1,378 $10.29 $14,179.62
Disclosure

SEC source: 0001415889-23-015446 · form4-11222023_111131.xml · nonDerivative · entry 2

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 331,206

F2 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 23:11 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 7,363 $10.37 $76,354.31
Disclosure

SEC source: 0001415889-23-015450 · form4-11222023_111146.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 278,279

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

F2 · balance_after: Includes 345 shares acquired under the Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan on November 15, 2023.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 23:07 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 7,982 $10.37 $82,773.34
Disclosure

SEC source: 0001415889-23-015446 · form4-11222023_111131.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 332,584

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 23:16 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 15,804 $10.37 $163,887.48
Disclosure

SEC source: 0001415889-23-015454 · form4-11222023_111107.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,595,965

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 23:14 UTC
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER
Tax withholdingOrdinary Shares 6,187 $10.37 $64,159.19
Disclosure

SEC source: 0001415889-23-015452 · form4-11222023_111102.xml · nonDerivative · entry 1

Sawaf Aziz · CIK 0001961289 · SVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 255,672

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 20, 2023 Filed Nov 22, 2023 23:10 UTC
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
Tax withholdingOrdinary Shares 12,630 $10.37 $130,973.10
Disclosure

SEC source: 0001415889-23-015448 · form4-11222023_111154.xml · nonDerivative · entry 1

GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 334,209

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
November 14, 2023 Filed Nov 16, 2023 23:16 UTC
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
SaleOrdinary Shares 2,482 $10.22 $25,366.04
Disclosure

SEC source: 0001415889-23-015228 · form4-11162023_111124.xml · nonDerivative · entry 1

GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 346,839

F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.

Read SEC document
October 30, 2023 Filed Nov 1, 2023 22:35 UTC
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
GrantOrdinary Shares 15,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-23-014680 · form4-11012023_101136.xml · nonDerivative · entry 1

GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349,321

F1 · shares: On March 1, 2023 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of a performance condition by December 31, 2023 and continued employment. On October 30, 2023 the performance conditions were achieved. As a result 50% of the restricted stock units will vest on November 20, 2023 and the remaining 50% of the restricted stock units will vest on November 20, 2024, subject to the reporting person's continued service.

Read SEC document
October 16, 2023 Filed Oct 18, 2023 22:54 UTC
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
SaleOrdinary Shares 2,482 $9.03 $22,412.46
Disclosure

SEC source: 0001415889-23-014412 · form4-10182023_101010.xml · nonDerivative · entry 1

GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 334,321

F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.

Read SEC document
September 14, 2023 Filed Sep 18, 2023 22:08 UTC
GRAHAM RICHARD ASVP, RESEARCH & DEVELOPMENT
SaleOrdinary Shares 2,482 $9.89 $24,546.98
Disclosure

SEC source: 0001415889-23-013342 · form4-09182023_100948.xml · nonDerivative · entry 1

GRAHAM RICHARD A · CIK 0001820036 · SVP, RESEARCH & DEVELOPMENT

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 336,803

F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.

Read SEC document
August 22, 2023 Filed Aug 24, 2023 22:05 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
SaleOrdinary Shares 1,807 $9.47 $17,112.29
Disclosure

SEC source: 0001415889-23-012621 · form4-08242023_100801.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 340,566

F1 · shares: This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/09/2023.

Read SEC document
August 20, 2023 Filed Aug 22, 2023 22:15 UTC
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY
Tax withholdingOrdinary Shares 8,912 $9.70 $86,446.40
Disclosure

SEC source: 0001415889-23-012517 · form4-08222023_100856.xml · nonDerivative · entry 1

Grimaud Brett A. · CIK 0001966698 · SVP, GEN COUNSEL AND SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,297

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2023 Filed Aug 22, 2023 22:10 UTC
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
Tax withholdingOrdinary Shares 10,460 $9.70 $101,462.00
Disclosure

SEC source: 0001415889-23-012510 · form4-08222023_100816.xml · nonDerivative · entry 1

Farnum Rhonda · CIK 0001898490 · SVP, COMM & MEDICAL AFFAIRS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 342,373

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document
August 20, 2023 Filed Aug 22, 2023 22:19 UTC
Winningham Rick EDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingOrdinary Shares 15,804 $9.70 $153,298.80
Disclosure

SEC source: 0001415889-23-012522 · form4-08222023_100811.xml · nonDerivative · entry 1

Winningham Rick E · CIK 0001302443 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,611,769

F1 · shares: Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.